Drawing for NAMCELNO

USPTO serial 79201264

NAMCELNO

Reviewed by CopyMark Law Group

Reg. 5220586Status 709
Filing date
Status date
Registration date
Jun 13, 2017
Examiner
WATTS-FITZGERALD, CAITLIN C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NAMCELNO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and compositions for the treatment and prevention of cancerSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 17, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 17, 2024INPCINVALIDATION PROCESSED—
Aug 30, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 29, 2023C71TCANCELLED SECTION 71—
Oct 23, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 4, 2017GPNXNOTIFICATION PROCESSED BY IB—
Jul 19, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 19, 2017FIMPFINAL DISPOSITION PROCESSED—
Jul 13, 2017GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jun 13, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 8, 2017NPUBNOTICE OF PUBLICATION—
Feb 17, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 13, 2017DOCKASSIGNED TO EXAMINER—
Feb 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 10, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 9, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance